prostate carcinoma on overall QOL in the two treatment groups. The PCTO-Q of Minnesota Medical School, Minneapolis, assessed the patients' perceptions of the incidence and severity of specific changes Minnesota. in bowel, urinary, and sexual functions. The test-retest reliability of the PCTO-Q in a
Quality of life changes during conformal radiation therapy for prostate carcinoma
✍ Scribed by Monika Janda; Natascha Gerstner; Andreas Obermair; Annerose Fuerst; Stefan Wachter; Karin Dieckmann; Richard Pötter
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 88 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
The objective of this study was to describe prospectively quality of life (QOL) before and after radiotherapy for patients with prostate carcinoma.
METHODS.
Forty-three patients with T1-T3 prostate carcinoma who underwent conformal external beam radiation therapy were randomized either to the complete European Organization for Research and Treatment of Cancer (EORTC) QOL questionnaire (EORTC QLQ-C30) or the Medical Outcomes Study Group Short Form Health Survey (SF-36) at baseline, at 3 weeks and 6 weeks after initial treatment, and at 6 weeks and 5 months after the completion of radiotherapy. The measures were self-reported patient QOL, and values are given as the mean Ϯ standard error of the mean. Changes in QOL are described from baseline to the end of treatment in both questionnaire groups.
RESULTS.
Emotional role functioning, as measured with the SF-36 questionnaire, significantly improved from 68.2 Ϯ 9.9 at baseline to 93.3 Ϯ 5.2 at the end of therapy (P ϭ 0.02). The EORTC QLQ-C30 questionnaire revealed consistent values of emotional functioning during treatment (72.7 Ϯ 5.9 at baseline) but showed a significant improvement 6 weeks after therapy (89.0 Ϯ 4.4; P ϭ 0.01). Role functioning deteriorated from 80.1 Ϯ 6.5 at baseline to 62.5 Ϯ 8.8 at the end of radiotherapy (P ϭ 0.02). Symptoms of fatigue were shown to increase significantly from 26.9 Ϯ 6.0 at baseline to 37.7 Ϯ 7.6 at the end of therapy (P ϭ 0.02). No significant changes in the other dimensions were observed in either questionnaire.
CONCLUSIONS.
After radiotherapy for prostate carcinoma, patients experience a temporary deterioration of fatigue and role functioning, as measured with the EORTC QLQ-C-30. Despite physical deterioration, the authors observed an improvement in emotional functioning scores with both questionnaires. This may have been due to psychological adaptation and coping.
📜 SIMILAR VOLUMES
## BACKGROUND. Cryosurgery was introduced as an alternative to radiotherapy or radical prostatectomy in the mid-1960s. Although it met the primary objective of achieving local control, it was largely abandoned due to a high incidence of complications. Technologic advances in the areas of imaging a
## BACKGROUND. There is limited information on outcomes of prostate carcinoma treatments given to screened patient populations for whom cancer is usually detected at an earlier stage. ## METHODS. The authors conducted a cross-sectional evaluation of quality-of-life outcomes for men with prostate
## BACKGROUND. The purpose of this study was to evaluate the effect of breast irradiation on quality of life, including cosmetic outcome, for patients enrolled in a clinical trial. ## METHODS. Between 1984 and 1989, a randomized trial was conducted in Ontario, Canada, in which women with lymph no